Patient involvement in clinical research: why, when, and how
JA Sacristán, A Aguarón… - Patient preference …, 2016 - Taylor & Francis
The development of a patient-centered approach to medicine is gradually allowing more
patients to be involved in their own medical decisions. However, this change is not …
patients to be involved in their own medical decisions. However, this change is not …
Cannabinoids in the treatment of epilepsy
D Friedman, O Devinsky - New England Journal of Medicine, 2015 - Mass Medical Soc
Cannabinoids in the Treatment of Epilepsy | NEJM Skip to main content NEJM Group Follow Us
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …
Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer
Background Clinical trials that study cancer are essential for testing the safety and
effectiveness of promising treatments, but most people with cancer never enroll in a clinical …
effectiveness of promising treatments, but most people with cancer never enroll in a clinical …
Charting a course for genomic medicine from base pairs to bedside
ED Green, MS Guyer… - Nature, 2011 - nature.com
There has been much progress in genomics in the ten years since a draft sequence of the
human genome was published. Opportunities for understanding health and disease are now …
human genome was published. Opportunities for understanding health and disease are now …
[图书][B] The ethics of research with human subjects: Protecting people, advancing science, promoting trust
DB Resnik - 2018 - Springer
Research with human subjects 1 exemplifies the perennial conflict between the good of the
individual and the good of society. Policies and procedures that protect the rights and …
individual and the good of society. Policies and procedures that protect the rights and …
HIV treatment as prevention and HPTN 052
MS Cohen, M McCauley… - Current Opinion in HIV and …, 2012 - journals.lww.com
HPTN 052 required many years of preparation, considerable collaboration between
National Institute of Health and six pharmaceutical companies, and careful ongoing …
National Institute of Health and six pharmaceutical companies, and careful ongoing …
From genetics to genomics: facing the liability implications in clinical care
G Marchant, M Barnes, JP Evans, B LeRoy… - Journal of Law …, 2020 - cambridge.org
Health care is transitioning from genetics to genomics, in which single-gene testing for
diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other …
diagnosis is being replaced by multi-gene panels, genome-wide sequencing, and other …
Phase 1 safety trial of autologous human schwann cell transplantation in chronic spinal cord injury
A phase 1 open-label, non-randomized clinical trial was conducted to determine feasibility
and safety of autologous human Schwann cell (ahSC) transplantation accompanied by …
and safety of autologous human Schwann cell (ahSC) transplantation accompanied by …
[图书][B] Good science: The ethical choreography of stem cell research
C Thompson - 2013 - books.google.com
An examination of a decade and a half of political controversy, ethical debate, and scientific
progress in stem cell research. After a decade and a half, human pluripotent stem cell …
progress in stem cell research. After a decade and a half, human pluripotent stem cell …
The ethics of smart pills and self-acting devices: autonomy, truth-telling, and trust at the dawn of digital medicine
CM Klugman, LB Dunn, J Schwartz… - The American journal of …, 2018 - Taylor & Francis
Digital medicine is a medical treatment that combines technology with drug delivery. The
promises of this combination are continuous and remote monitoring, better disease …
promises of this combination are continuous and remote monitoring, better disease …